Women looking for a simple alternative to traditional methods of sterilization have turned to the Essure Permanent Birth Control System, which is marketed and sold by Bayer. The contraceptive device was originally developed by Conceptus Inc. and approved in 2002. Bayer purchased Conceptus and the rights to the Essure System in 2013 and is now under fire for numerous complications that women using the system have suffered. These complications are so severe that the FDA has implemented a black box warning for the devices— which requires patients to sign a waiver stating that they have been notified of the risks associated with the devices prior to use.
How the Essure System Works
The Essure Permanent Birth Control System is a non-hormonal birth control method that prevents pregnancy through sterilization. Two flexible coils are inserted into the fallopian and over time, scar tissue develops around the coils and causes permanent infertility by creating a barrier that prevents eggs from reaching the uterus. The simple outpatient procedure has made the system an attractive alternative to tubal litigation and the devices can be inserted without any need for anesthesia.